BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Clinical trials for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM trials appear
Sign up with your email to follow new studies for BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancer: targeted drug shows promise in early trial
Disease control CompletedThis early-phase study tested the drug venetoclax in 5 adults with a rare and aggressive blood cancer called BPDCN. The goal was to see if the drug is safe and can shrink tumors. Participants had already tried other treatments. The study looked at side effects and how well the ca…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Selective t cell removal may reduce transplant complications in leukemia patients
Disease control CompletedThis study tested a method to prevent graft-versus-host disease (GVHD) in 84 leukemia patients receiving donor stem cell transplants. By removing a specific type of immune cell (naive T cells) from the donor graft, researchers aimed to lower GVHD risk while preserving infection-f…
Matched conditions: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC